Therapeutic Response of Meniere’s Disease Utilizing Sorbus domestica February 6, 2024https://www.cureus.com/articles/177520-therapeutic-response-of-menieres-disease-utilizing-sorbus-domestica#!/
Long-term effects of middle ear pressure therapy with the EFET01 device in patients with Ménière’s disease in Japan January 5, 2024https://www.tandfonline.com/doi/full/10.1080/00016489.2023.2284336
Clinical severity staging system may aid treatment selection for Meniere disease September 6, 2023https://medicalxpress.com/news/2023-09-clinical-severity-staging-aid-treatment.html
Progress with SPT-2101 for Meniere’s Disease: Encouraging data from the Australian clinical trial August 30, 2023https://www.biospace.com/article/releases/spiral-therapeutics-welcomes-new-investment-cementing-its-leadership-in-neurotology/?s=105
Phase 1 Study of SPT-2101 Given as a Single Intratympanic Injection in Subjects with Unilateral Meniere’s Disease August 30, 2023https://www.australianclinicaltrials.gov.au/anzctr/trial/ACTRN12621000964819
Meniere’s disease: Pathogenesis, treatments, and emerging approaches August 28, 2023https://www.sciencedirect.com/science/article/pii/S0013935123017760?via%3Dihub
Two Distinct Patient Groups ID’d in Meniere Disease August 10, 2023https://www.physiciansweekly.com/two-distinct-patient-groups-idd-in-meniere-disease/
3D analysis of inner ear provides insights into Ménière’s disease August 7, 2023https://www.news-medical.net/news/20230807/3D-analysis-of-inner-ear-provides-insights-into-Menieres-disease.aspx
Vestibular Function Tests ID Vestibular Migraine Versus Meniere Disease July 7, 2023https://consumer.healthday.com/physician-s-briefing-meniere-2662226583.html
Radiological feature heterogeneity supports etiological diversity among patient groups in Meniere’s disease June 26, 2023https://www.nature.com/articles/s41598-023-36479-5
Assessing the Efficacy of a Serotonin and Norepinephrine Reuptake Inhibitor for Improving Meniere’s Disease Outcomes May 22, 2023https://classic.clinicaltrials.gov/ct2/show/NCT04218123
Comparison of clinical characteristics and vestibular function test results in patients with vestibular migraine and Menière’s disease May 16, 2023https://www.sciencedirect.com/science/article/pii/S1808869423000368?via%3Dihub
Sound Pharma completes enrollment in pivotal Phase 3 clinical trial of SPI-1005 for the treatment of Meniere’s disease involving hearing loss, tinnitus, and dizziness. May 3, 2023https://www.prnewswire.com/news-releases/sound-pharma-completes-enrollment-in-pivotal-phase-3-clinical-trial-of-spi-1005-for-the-treatment-of-menieres-disease-involving-hearing-loss-tinnitus-and-dizziness-301814797.html
